The Direxion Daily Healthcare Bull 3X Shares seeks daily investment results, before fees and expenses, of 300% of the performance of the Health Care Select Sector Index. This index tracks large-cap U.S. companies in the healthcare sector, encompassing pharmaceuticals, biotechnology, healthcare providers and services, medical equipment, and life sciences tools.
The ETF employs leveraged exposure through a combination of securities, derivatives such as swaps, and cash equivalents to achieve its daily target. Top holdings mirror the underlying index concentration, with significant weight in companies such as Eli Lilly, Johnson & Johnson, AbbVie, Merck, and UnitedHealth Group. Sector allocation is 100% healthcare, with no geographic diversification beyond U.S.-listed equities.
This structure drives the ETF’s performance through amplified daily movements in the healthcare sector. Its positioning offers tactical opportunities for investors seeking magnified exposure to sector growth themes, though the daily reset requires active monitoring to align with short-term market views.
Federal Reserve interest rate decisions could influence borrowing costs and equity valuations across healthcare, particularly for capital-intensive segments such as biotechnology and medical devices. Lower rates generally support higher multiples for growth companies within the sector.
Inflation trends and economic growth expectations affect consumer and payer spending on healthcare services, while also influencing input costs for manufacturers. Stronger economic data may bolster overall market risk appetite, benefiting leveraged sector exposure.
Earnings outlooks for major holdings remain pivotal, as pipeline advancements, clinical trial results, and product launches in pharmaceuticals and biotechnology can drive significant index-level moves. Regulatory developments around drug pricing or reimbursement policies represent additional potential catalysts.
ETF inflow and outflow trends may accelerate with renewed institutional interest in healthcare themes, amplifying liquidity and visibility for the leveraged product during periods of sector strength.
The healthcare sector operates within a complex macroeconomic environment where interest rates affect discount rates applied to future cash flows of innovative therapies and equipment. Lower rate environments tend to favor growth-oriented segments, while higher rates may emphasize defensive characteristics of established providers.
Inflation and economic growth expectations shape demand dynamics, with healthcare often exhibiting relative resilience due to essential nature of its products and services. Global market trends and currency movements can indirectly influence multinational healthcare firms through international revenue exposure.
Equity market trends and broader risk sentiment drive flows into sector indices, with the underlying Health Care Select Sector Index serving as the benchmark for leveraged products. Bond market conditions also play a role, as fixed-income yields compete with equity returns in investor portfolios.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments. The product includes searchable prediction categories, historical context, and alert-oriented functionality. Trend Prediction Engine
Long-term sector growth is supported by demographic trends, particularly the aging global population that increases demand for chronic disease management, pharmaceuticals, and healthcare services. Technology adoption in areas such as precision medicine, digital health, and advanced medical devices continues to expand the addressable market.
Economic cycles and interest rate cycles influence capital allocation toward healthcare innovation, while market structure changes, including consolidation among providers and payers, may reshape competitive dynamics. Global investment trends favor sectors with defensive growth characteristics amid evolving geopolitical and trade environments.
The outlook for the underlying index remains tied to sustained innovation pipelines and structural healthcare needs, positioning leveraged exposure to capture amplified participation in these enduring themes over multi-year horizons.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Category Trading
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with QULL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then QULL could also see price increases.
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | -0.55% | ||
| QULL - CURE | 50% Loosely correlated | N/A | ||
| SSO - CURE | 37% Loosely correlated | +1.03% | ||
| SPXL - CURE | 36% Loosely correlated | +1.54% | ||
| IFED - CURE | 33% Loosely correlated | -0.09% | ||
| TSLL - CURE | 30% Poorly correlated | +3.58% | ||
More | ||||
The Moving Average Convergence Divergence (MACD) for CURE turned positive on May 12, 2026. Looking at past instances where CURE's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 04, 2026. You may want to consider a long position or call options on CURE as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CURE moved above its 50-day moving average on June 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CURE crossed bullishly above the 50-day moving average on May 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 242 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CURE broke above its upper Bollinger Band on June 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.